Credit of Final Cash Dividend

Published in The NEWS & Nawa-e-Waqt

GlaxoSmithKline Pakistan Limited

CREDIT OF FINAL CASH DIVIDEND (D-96)
FOR THE YEAR ENDED DECEMBER 31, 2018

We are pleased to inform our Shareholders that 70% Final Cash Dividend i.e. Rs. 7/- per share for the year ended December 31, 2018, approved at 72nd Annual General Meeting of the Company held on April 24, 2019, has been credited through electronic mode on May 13, 2019 directly into the designated bank accounts of the Shareholders who have submitted their valid Computerized National Identity Card (CNIC) and valid International Bank Account Number (IBAN) with complete details.

In compliance with the requirements of Companies Act, 2017 and Companies (Distribution and Dividends) Regulations, 2017, the Company has withheld dividend of those shareholders who have provided incomplete bank details.

Accordingly, shareholders are advised to contact the Company’s Shares Registrar/CDC/Broker along with a legible and valid copy of their CNIC/SNIC and provide complete bank details including 24-digit IBAN by filing the form posted at the Company’s website i.e. http://www.pk.gsk.com.

Central Depository Company (CDC) has developed Centralized Cash Dividend Register (CCDR), on e-Services web portal, which would incorporate details pertaining to cash dividend paid, unpaid or withheld by listed companies. The CCDR will help to maintain the history of dividends paid to shareholders by listed companies and access of all such information will be provided to the respective shareholders; including details of Income Tax/Zakat deduction (if any) and the net amount credited into their accounts.

The Shareholders are requested to register themselves to CDC’s e-Services Portal https://eservices.cdcaccess.com.pk/ to avail the above facility.

Syed Azeem Abbas Naqvi
Company Secretary

Karachi
Dated: May 15, 2019